Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2023, 32(2):138-141

Prediction of left ventricular reverse remodelling. Mini review on clinical aspects

Chudy M, Goncalvesova E
Department of Heart Failure and Transplantation, Faculty of Medicine, Comenius University and National Cardiovascular Institute, Bratislava, Slovakia

Published: February 1, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chudy M, Goncalvesova E. Prediction of left ventricular reverse remodelling. Mini review on clinical aspects. Cardiology Letters. 2023;32(2):138-141.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Wilcox JE, Fang JC, Margulies KB, Mann DL. Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel. J Am Coll Cardiol. 2020 Aug;76:719-734. Go to original source...
    2. He Y, Ling Y, Guo W, Li Q, Yu S, Huang H, et al. Prevalence and Prognosis of HFimpEF Developed From Patients With Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis. Front Cardiovasc Med. 2021 Nov 25;8:757596. Go to original source...
    3. Merlo M, Pyxaras S, Pinamonti B, G B, A DL, G S. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol. 2011 Mar 29;57:1468-1476. Go to original source...
    4. Ye L, Li X, Wang S, Wang Y, Zheng Y, Wang L. Body Mass Index: An Effective Predictor of Ejection Fraction Improvement in Heart Failure. Front Cardiovasc Med. 2021 Dec 1;8. Go to original source...
    5. Wilcox JE, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Heywood JT, et al. Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: Findings from IMPROVE HF. Am Heart J. 2012 Jan 1;163:49-56. e2. Go to original source...
    6. Florea VG, Rector TS, Anand IS, Cohn JN. Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival. Circ Hear Fail. 2016 Jul 1;9: e003123. Go to original source...
    7. Lupón J, Gaggin H, de Antonio M, M D, A G, E Z, et al. Biomarkerassist score for reverse remodeling prediction in heart failure: The ST2-R2 score. Int J Cardiol. 2015;184:33-343. Go to original source...
    8. Amorim S, Rodrigues J, Campelo M, Moura B, Martins E, Macedo F, et al. Left ventricular reverse remodeling in dilated cardiomyopathy-maintained subclinical myocardial systolic and diastolic dysfunction. Int J Cardiovasc Imaging. 2017 May 1;33:605-613. Go to original source...
    9. Choi JO, Kim EY, Lee GY, Lee SC, Park SW, Kim DK, et al. Predictors of left ventricular reverse remodeling and subsequent outcome in nonischemic dilated cardiomyopathy. Circ J. 2013;77:462-469. Go to original source...
    10. Park SM, Kim YH, Ahn CM, Hong SJ, Lim DS, Shim WJ. Relationship between ultrasonic tissue characterization and myocardial deformation for prediction of left ventricular reverse remodelling in non-ischaemic dilated cardiomyopathy. Eur J Echocardiogr. 2011 Dec;12:887-894. Go to original source...
    11. Masci PG, Schuurman R, Andrea B, Ripoli A, Coceani M, Chiappino S, et al. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging. 2013 Sep;6:790-799. Go to original source...
    12. Barison A, Aimo A, Ortalda A, Todiere G, Grigoratos C, Passino C, et al. Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy. Int J Cardiol. 2018 Jan 1;250:195-200. Go to original source...
    13. Sarhene M, Wang Y, Wei J, Huang Y, Li M, Li L, et al. Biomarkers in heart failure: the past, current and future [Internet]. Heart Failure Rev. 2019: 24:867-903. Go to original source...
    14. Gaggin HK, Szymonifka J, Bhardwaj A, Belcher A, De Berardinis B, Motiwala S, et al. Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients With Chronic Heart Failure. JACC Hear Fail. 2014 Feb;2:65-72. Go to original source...
    15. Basuray A, French B, Ky B, Vorovich E, Olt C, Sweitzer NK, et al. Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes. Circulation. 2014 Jun 10;129:2380-2387. Go to original source...
    16. Kalogeropoulos AP, Fonarow GC, Georgiopoulou V, Burkman G, Siwamogsatham S, Patel A, et al. Characteristics and outcomes of adult outpatients with heart failure and improved or recovered ejection fraction. JAMA Cardiol. 2016 Aug 1;1:510-518. Go to original source...
    17. Wohlfahrt P, Nativi-Nicolau J, Zhang M, CH S, T G, J C, et al. Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. JAMA Cardiol. 2021;E1-6. Go to original source...

    Return to the content